Federal Circuit: Aggregated Financial Data From Different Products That Practice Different Patents Insufficient to Establish Domestic Industry

July 10, 2024

Reading Time : 2 min

In an appeal from the ITC, the Federal Circuit recently held that by presenting cumulative financial data across different products that practice various combinations of patents, appellant provided insufficient evidence for a court to evaluate domestic industry for any individual patent. And as a result, the court affirmed the ITC’s determination that the appellant failed to satisfy its burden to establish a domestic industry for any of its asserted patents.

The technology in this case related to stud finders. The appellant in this case asserted three patents each of which covered different features of its stud finder technology, including methods of calibration and features of the grips. In an effort to show domestic industry at the ITC, the appellant alleged that it met the domestic industry requirement based on investments in manufacturing, labor and capital, research and development, and the exploitation of its patents. As evidence of these investments, appellant provided financial data across 53 different products. Not all 53 products, however, practiced all three patents. Rather, only 14 of the 53 products practiced at least one claim of each asserted patent. The remaining products practiced only one or two of the asserted patents. But appellant’s domestic industry evidence aggregated the financial data for all products—it did not allocate the investments separately by product or patent.

At the ITC, the administrative law judge (ALJ) found that this evidence did not satisfy the economic prong for any of the asserted patents because it did not show a substantial or significant investment specific to any particular patent. On review, the ITC upheld the ALJ’s determination, explaining that instead of establishing domestic industry for products protected by each asserted patent, the complainant “aggregated its domestic industry products without regard for whether or which patents they practiced and then argued that a domestic industry in all of its products exists.” The aggregated information “failed to provide the Commission with an adequate basis to evaluate the investments and the significance of those investments with respect to each asserted patent.”

On appeal, appellant argued that Section 337 permits it to rely on investment data in the aggregate, so long as it ties expenditures to articles that practice some or all of the asserted patents. In other words, it need not show investments on a patent-by-patent basis.

The Federal Circuit rejected this argument, adopting the reasoning of the ALJ and ITC. As the court explained, a complainant must show “how much of its investment in each statutory category was attributable to each group of products” that practices an asserted patent. Thus, while it may be possible to aggregate data in certain circumstances, such as where all of the products practice all of the patents, such a method was inappropriate here where many of the products practiced fewer than all of the asserted patents. The court also confirmed its decision here does not preclude a party from grouping data for products that practice the same patents, so long as domestic industry can be determined for each patent.

Practice Tip: This case illustrates that, similar to damages apportionment, parties should give attention to ensuring that domestic industry evidence connects specific products to the specific patents they practice and does not depend on data for products that are not covered by the claims.

Zircon Corp. v. Int’l Trade Comm’n, 101 F.4d 817, 818 (Fed. Cir. 2024).

Share This Insight

Previous Entries

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

IP Newsflash

January 17, 2025

The District of Arizona recently held that a plaintiff’s failure to mark patented products during the time period that marking was required barred it from recovering all pre-notice damages, including for a period of time when there was no obligation to mark.

...

Read More

IP Newsflash

January 16, 2025

The Unified Patent Court (UPC) aims to provide expeditious decisions for its litigants. That means that there is a higher bar for obtaining extensions of time. As exemplified in BMW v. ITCiCo, the UPC’s reluctance to grant extensions can have serious consequences, including revocation of the patent.

...

Read More

IP Newsflash

January 15, 2025

The Patent Trial and Appeal Board granted institution of inter partes review of a patent directed to delivery of targeted television advertisements. The board rejected patent owner’s argument that a lack of particularity as to the asserted grounds justified denial under 35 U.S.C. § 312(a), holding that “simply including a significant amount of testimony and a number of supporting references is not, by itself, a reason to find that the particularity requirement is not met.”

...

Read More

IP Newsflash

December 2, 2024

The Patent Trial and Appeal Board determined that a reference could be used as prior art because patent owner failed to provide sufficient evidence that the prior art’s disclosure was invented by all four named inventors, and thus the same “inventive entity,” as the challenged claims.

...

Read More

IP Newsflash

December 2, 2024

The Patent Trial and Appeal Board rejected a patent owner’s assertion that petitioner should have named a third party, which was a defendant in a related district court patent infringement litigation and a party to a joint defense agreement (JDA) with petitioner, as a real party-in-interest (RPI). Had the board ruled otherwise and found the third party to be an RPI, the petition would have been time-barred under 35 U.S.C. § 315(b).

...

Read More

IP Newsflash

November 27, 2024

A district court recently refused to exclude testimony regarding consumer surveys conducted by a design patent expert, holding instead that the consumer surveys may be probative of how an ordinary observer would view the designs at issue, and thus could assist the factfinder in determining design patent infringement under the ordinary observer test.

...

Read More

IP Newsflash

November 5, 2024

The Federal Circuit vacated a district court’s fee award because the district court considered certain information that was not relevant to the question of whether plaintiff’s case was exceptional. Specifically, the Federal Circuit held that only those “red flags” that related to the successful Section 101 defense, which served as the basis for the district court’s grant of summary judgment, could be used to show the case was fatally flawed.   

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.